Home Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components
Article
Licensed
Unlicensed Requires Authentication

Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components

  • Norbert Laube , Allen Rodgers , Shameez Allie-Hamdulay and Michael Straub
Published/Copyright: June 26, 2008

Abstract

Background: Although afflicted with stone formation, urolithiasis patients often present with normal renal excretions of lithogenic and inhibitory substances. In this study, crystal formation is not interpreted as the result of urinary excretions simply exceeding the static limits of normal ranges but rather as the consequence of relative combinations of such parameters which convert urine into becoming potentially lithogenic. Our model embraces different triplet combinations of fundamental urinary risk factors for calcium oxalate (CaOx) crystallization, to characterize different levels of urinary stone formation risk.

Methods: Urinalyses and BONN-Risk-Indices (BRI) were determined for CaOx patients under home conditions, after 1 week of hospitalization, and for healthy controls. The relative urinary concentrations and interdependences of, inter alia, free ionized Ca ({Ca2+}), bound Ca ({Cab}), and oxalic acid ({OA}) were compared.

Results: Three levels of CaOx formation risk can be distinguished: (I): low stone formation risk with an increase in {Ca2+} and concomitant decrease in {Cab}, while {OA} remains almost constant, BRI increases simultaneously; (II) moderate risk at {Ca2+}/{Cab}≈1; and (III) high risk with decrease in {Ca2+}/{Cab} and simultaneous increase in {OA}.

Conclusions: The proposed approach of urinalysis interpretation allows complementary strategy of identification of patterns of disturbed urinary composites leading to calculus formation.

Clin Chem Lab Med 2008;46:1134–9.


Corresponding author: Norbert Laube, PhD, Klinik und Poliklinik für Urologie, Experimentelle Urologie, Sigmund-Freud-Straße 25, 53105 Bonn, Germany Phone: +49-228-2871-9106, Fax: +49-228-2871-4329,

Received: 2008-1-22
Accepted: 2008-4-7
Published Online: 2008-06-26
Published in Print: 2008-08-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia
  3. Minireview
  4. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
  5. Genetics and Molecular Diagnostics
  6. Proteomic pattern of plasma in off-pump coronary artery bypass surgery
  7. Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population
  8. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers
  9. Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients
  10. The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism – The Cardiovascular Risk in Young Finns Study
  11. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP
  12. An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value
  13. General Clinical Chemistry and Laboratory Medicine
  14. Can E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients?
  15. Determination of serum creatinine by Jaffe method and how to calibrate to eliminate matrix interference problems
  16. Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components
  17. Half-lives of albumin and cholinesterase in critically ill patients
  18. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood
  19. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-α levels in patients with ischemic heart disease
  20. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures
  21. Are serum lipids measured on stroke admission prognostic?
  22. Reference Values and Biological Variations
  23. Pre-analytical variation of some haematological quantities
  24. Long-term stability of endogenous B-type natriuretic peptide after storage at –20°C or –80°C
  25. Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?
  26. Non-homogeneous separation of triglycerides, γ-glutamyltransferase, C-reactive protein and lactate dehydrogenase after centrifugation of lithium-heparin tubes
  27. Validation and Outcome Studies
  28. Computer-assisted detection of monoclonal components: results from the multicenter study for the evaluation of CASPER (Computer Assisted Serum Protein Electrophoresis Recognizer) algorithm
  29. Quality indicators and specifications for strategic and support processes in laboratory medicine
  30. Evaluation of the DCA Vantage analyzer for HbA1c assay
  31. Letters to the Editor
  32. Optimization of imprecision and cost saving on hemoglobin A1c controls through aliquot freezing
  33. Estimation of glomerular filtration rate by the modification of diet in renal disease (MDRD) equation in patients with sickle cell disease
  34. Abstracts
  35. Swiss MedLab 2008: International Congress, September 16–19, 2008, Montreux, Switzerland
  36. 4th Biologie Prospective Santorini Conference, September 21–23, 2008, Santorini, Greece
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.222/html
Scroll to top button